Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

40.92 +2.88 (+7.58%)
Streaming Delayed Price Updated: 1:53 PM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
From Twist Bioscience Corporation
Via Business Wire
News headline image
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
News headline image
Why Shares of Twist Bioscience Are Up Friday ↗
The company reported improved financials in the third quarter. 
Via The Motley Fool
News headline image
Twist Bioscience Stock Soars After Q3 Report - Here's Why ↗
Twist Bioscience Corp (NASDAQ: TWST) reported Q3 sales increased 14% Y/Y to $63.7 million, beating the consensus of $60.71 million. 
Via Benzinga
News headline image
Twist Bioscience's Earnings Outlook ↗
 
Via Benzinga
News headline image
Analyst Ratings for Twist Bioscience ↗
 
Via Benzinga
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
From Twist Bioscience Corporation
Via Business Wire
News headline image
Analyst Ratings for Twist Bioscience ↗
 
Via Benzinga
News headline image
Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential ↗
DNA powers almost all biotechnology applications today. These leading DNA stocks are ready to reap the rewards of a growing industry. 
Via InvestorPlace
News headline image
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
From Twist Bioscience Corporation
Via Business Wire
News headline image
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Earnings Scheduled For August 4, 2023 ↗
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter. 
Via Benzinga
News headline image
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
From Twist Bioscience Corporation
Via Business Wire
News headline image
2 Cathie Wood Growth Stocks That Could Make You Richer ↗
These two biotechs could be winning plays for aggressive investors. 
Via The Motley Fool
News headline image
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
From Twist Bioscience Corporation
Via Business Wire
News headline image
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 
Via Benzinga
News headline image
3 DNA Stocks to Buy for the Synthetic Biology Revolution ↗
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche. 
Via InvestorPlace
News headline image
Elliott Wave Technical Analysis: Twist Bioscience Corp. - Wednesday, May 10 ↗
Looking for shorts once we have signs wave (iv) is complete. 
Via Talk Markets
News headline image
Twist Bioscience to Present at ITF World 2023
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.